Showing 8841-8850 of 18571 results for "".
- Obesity and Dementia: Unraveling the Direct Link and Its Clinical Implicationshttps://reachmd.com/news/obesity-and-dementia-unraveling-the-direct-link-and-its-clinical-implications/2485423/A recent study finds that higher body mass index and elevated blood pressure are direct causal contributors to dementia, reframin
- Podium Introduces Artificial Intelligence Operating System Designed for Aesthetic Practiceshttps://reachmd.com/news/podium-introduces-artificial-intelligence-operating-system-designed-for-aesthetic-practices/2485420/Podium has announced the launch of an artificial intelligence (AI)–driven operating system designed specifically for aesthetic practices, positioning the platform as a unified alternative to the fragmented software ecosystems common in cosmetic dermatology practices. The company describes the pro
- Rising Glaucoma Burden and Innovative Treatment Horizons in the UKhttps://reachmd.com/news/rising-glaucoma-burden-and-innovative-treatment-horizons-in-the-uk/2485412/A recent national projection analysis indicates glaucoma prevalence in people aged over 40 will rise sharply, creating substantial long‑term service demand. The number of peo
- Stress Mindset and Psychological Adjustment: New Insights from Recent Studieshttps://reachmd.com/news/stress-mindset-and-psychological-adjustment-new-insights-from-recent-studies/2485405/A recent study of 709 adults found that psychological adjustment predicts tolerance for psychological pain, with perceived stress and stress mindset appearing as serial mediators. The inve
- Low-Dose Minocycline Superior in Treating Inflammatory Rosaceahttps://reachmd.com/news/low-dose-minocycline-dfd-29-superior-in-treating-inflammatory-rosacea/2485398/New data presented at 2026 Winter Clinical Hawaii showed DFD-29, a modified low-dose oral minocycline 40 mg, significantly outperformed both placebo and doxycycline 40 mg in the treatment of inflammatory lesions in patients with moderate-to-severe rosacea.
- Exploring Novel Epigenetic Inhibitors in Non-Small Cell Lung Cancerhttps://reachmd.com/news/novel-epigenetic-inhibitors-nsclc/2485389/Chemists at The University of Hong Kong report the development of an ATAC complex inhibitor that targets epigenetic drivers of non-small cel
- FDA Grants Nanotechnology Designation to Curiteva’s 3D-Printed PEEK Spinal Implantshttps://reachmd.com/news/fda-grants-nanotechnology-designation-to-curitevas-3d-printed-peek-spinal-implants/2485392/Curiteva has received a nanotechnology designation from the U.S. Food and Drug Administration (FDA) for its Inspire 3D Printed Trabecu
- New Data Show BMI Influences Psoriasis Severity and Systemic Inflammationhttps://reachmd.com/news/new-data-show-bmi-influences-psoriasis-severity-and-systemic-inflammation/2485411/Obesity and overweight status were associated with higher baseline prevalence of cardiometabolic comorbidities, psoriatic arthritis (PsA), and systemic inflammation compared to individuals with normal BMI, according to new data from a poster at 2026 Winter Clinical
- Genetic and Nutritional Insights: A New Frontier in Gut Motility and Inflammatory Bowel Diseasehttps://reachmd.com/news/genetic-and-nutritional-insights-a-new-frontier-in-gut-motility-and-inflammatory-bowel-disease/2485386/A genome-wide association study (GWAS) links 21 genomic regions to bowel-movement frequency and implicates vitamin B1 (thiamine)–related transport and metabolic pathways a
- Interferon Responses in Rhinovirus: Implications for Pulmonary Practicehttps://reachmd.com/news/interferon-responses-in-rhinovirus-implications-for-pulmonary-practice/2485365/New nasal-epithelium data show that interferon response determines rhinovirus outcomes—shaping symptom burden a